Inventor · disambiguated record
Nai-Kong V. Cheung
Also filed as: CHEUNG NAI-KONG · CHEUNG NAI-KONG V
52 granted patents·37 pending applications·780 citations·filing 1982–2025
98Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER47SLOAN KETTERING INST CANCER19CHEUNG NAI-KONG V7CHEUNG NAI-KONG4SLOAN KETTERING INST CANCER RES3
Top patents by PatentIndex Score
89 records- 0196US9062110B2Uses of monoclonial antibody 8H9SLOAN KETTERING INST CANCER·Filed 2013·Granted Jun 23, 2015·26 cites·10 claims
- 0296US8501471B2Uses of monoclonal antibody 8H9CHEUNG NAI-KONG V·Filed 2010·Granted Aug 6, 2013·27 cites·9 claims
- 0396US7462607B2Therapy-enhancing glucanSLOAN KETTERING INST CANCER·Filed 2005·Granted Dec 9, 2008·17 cites·19 claims
- 0495US9315585B2Anti-GD2 antibodiesCHEUNG NAI-KONG·Filed 2011·Granted Apr 19, 2016·29 cites·35 claims
- 0595US8414892B2Uses of monoclonal antibody 8H9CHEUNG NAI-KONG V·Filed 2010·Granted Apr 9, 2013·26 cites·3 claims
- 0695US6451995B1Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methodsSLOAN KETTERING INST CANCER·Filed 1997·Granted Sep 17, 2002·335 cites·8 claims
- 0794US9688772B2Anti-GD2 antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Jun 27, 2017·8 cites·33 claims
- 0894US9416422B2Methods for detecting minimum residual diseaseCHEUNG NAI-KONG·Filed 2006·Granted Aug 16, 2016·22 cites·11 claims
- 0993US9453075B2HLA-restricted, peptide-specific antigen binding proteinsCHEUNG NAI-KONG·Filed 2014·Granted Sep 27, 2016·20 cites·16 claims
- 1093US9040669B2HLA-restricted, peptide-specific antigen binding proteinsCHEUNG NAI-KONG·Filed 2012·Granted May 26, 2015·22 cites·16 claims
- 1193US8148154B2Method for preparation of single chain antibodiesCHEUNG NAI-KONG V·Filed 2010·Granted Apr 3, 2012·27 cites·7 claims
- 1293US7666424B2Methods of preparing and using single chain anti-tumor antibodiesSLOAN KETTERING INST CANCER·Filed 2002·Granted Feb 23, 2010·43 cites·9 claims
- 1392US10316093B2Antibodies, compositions, and usesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Jun 11, 2019·8 cites·26 claims
- 1491US10287365B2Anti-GD2 antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted May 14, 2019·5 cites·38 claims
- 1590US10519248B2Bispecific HER2 and CD3 binding moleculesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Dec 31, 2019·10 cites·20 claims
- 1690US8791252B2Therapy-enhancing glucanSLOAN KETTERING INST CANCER·Filed 2013·Granted Jul 29, 2014·8 cites·8 claims
- 1790US8633170B2Therapy-enhancing glucanCHEUNG NAI-KONG V·Filed 2010·Granted Jan 21, 2014·5 cites·23 claims
- 1890US7737258B2Uses of monoclonal antibody 8H9SLOAN KETTERING INST CANCER·Filed 2002·Granted Jun 15, 2010·22 cites·24 claims
- 1990US7507724B2Therapy-enhancing glucanSLOAN KETTERING INST CANCER·Filed 2003·Granted Mar 24, 2009·17 cites·26 claims
- 2089US11046768B2Bispecific HER2 and CD3 binding moleculesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Jun 29, 2021·5 cites·15 claims
- 2189US9211304B2Therapy-enhancing glucanSLOAN KETTERING INST CANCER·Filed 2013·Granted Dec 15, 2015·3 cites·20 claims
- 2288US8323644B2Therapy-enhancing glucanCHEUNG NAI-KONG V·Filed 2007·Granted Dec 4, 2012·10 cites·14 claims
- 2388US7740845B2Uses of monoclonal antibody 8H9SLOAN KETTERING INST CANCER·Filed 2003·Granted Jun 22, 2010·19 cites·18 claims
- 2487US9480700B2Therapy-enhancing glucanSLOAN-KETTERING INST FOR CANCER RES·Filed 2014·Granted Nov 1, 2016·2 cites·8 claims
- 2586US11091547B2Anti-chondroitin sulfate proteoglycan 4 antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Aug 17, 2021·4 cites·20 claims
- 2686US7704973B2Therapy-enhancing glucanSLOAN KETTERING INST CANCER·Filed 2004·Granted Apr 27, 2010·11 cites·14 claims
- 2785US11820832B2Bispecific HER2 and CD3 binding moleculesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Nov 21, 2023·2 cites·12 claims
- 2885US11555072B2A33 antibody compositions and methods of using the same in radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Jan 17, 2023·2 cites·21 claims
- 2984US10167341B2High affinity anti-GD2 antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2014·Granted Jan 1, 2019·4 cites·26 claims
- 3083US11597764B2Anti-L1-CAM antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Mar 7, 2023·3 cites·19 claims
- 3183US10988534B2Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Apr 27, 2021·2 cites·16 claims
- 3283US9802995B2Antibody multimerization technologiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2014·Granted Oct 31, 2017·5 cites·40 claims
- 3382US11117964B2Anti-KIR3DL1 antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Sep 14, 2021·4 cites·20 claims
- 3481US11583588B2Modular self assembly disassembly (SADA) technologiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Feb 21, 2023·2 cites·13 claims
- 3581US9938351B2Uses of monoclonal antibody 8H9SLOAN KETTERING INST CANCER RES·Filed 2016·Granted Apr 10, 2018·2 cites·8 claims
- 3681US7906492B2Therapy-enhancing glucanSLOAN KETTERING INST CANCER·Filed 2006·Granted Mar 15, 2011·1 cites·12 claims
- 3776US12343401B2Modular self assembly disassembly (SADA) technologiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Granted Jul 1, 2025·0 cites·11 claims
- 3875US2008193456A1Therapy-enhancing glucanCHEUNG NAI-KONG V·Filed 2008·Application pending·0 cites
- 3975US2025295794A1Modular self assembly disassembly (sada) technologiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2025·Application pending·0 cites
- 4074US12486323B2Anti-L1-CAM antibodies and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Granted Dec 2, 2025·0 cites·9 claims
- 4174US11987642B2Bispecific HER2 and CD3 binding moleculesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted May 21, 2024·0 cites·10 claims
- 4273US2024327511A1A33 antibody compositions and methods of using the same in radioimmunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 4371US11529371B2Anti-CD33 antibody agentsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Dec 20, 2022·1 cites·19 claims
- 4469US11858993B2Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Jan 2, 2024·0 cites·3 claims
- 4567US2014161814A1Uses of monoclonal antibody 8h9SLOAN KETTERING INST CANCER·Filed 2013·Application pending·0 cites
- 4667US2016166600A1Therapy-enhancing glucanBIOTEC PHARMACON ASA·Filed 2015·Application pending·0 cites
- 4766US10307479B2Therapy-enhancing glucanSLOAN KETTERING INST CANCER RES·Filed 2016·Granted Jun 4, 2019·0 cites·5 claims
- 4864US2013289101A1Therapy-enhancing glucanSLOAN KETTERING INST CANCER·Filed 2013·Application pending·0 cites
- 4963US2010216743A1Therapy-enhancing glucanSLOAN KETTERING INST CANCER·Filed 2010·Application pending·0 cites
- 5063US2021324079A1Bispecific her2 and cd3 binding moleculesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
Showing the top 50 of 89 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nai-Kong V. Cheung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →